How bacteria respond to a toxic molecule called methylglyoxal
The Role of Post-Translational Modifications in Bacterial Responses to Methylglyoxal
This study looks at how E. coli bacteria deal with a harmful substance called methylglyoxal, which they produce during their metabolism, and it aims to find out how changes to their proteins help them survive, with the hope that this could lead to better treatments for bacterial infections.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10899961 on NIH RePORTER |
What this research studies
This research investigates how bacteria, particularly E. coli, respond to methylglyoxal (MGO), a toxic byproduct of metabolism. The study focuses on understanding the role of post-translational modifications of proteins in bacterial survival under MGO stress. By examining the mechanisms that bacteria use to detoxify MGO and protect themselves, the research aims to uncover new insights into bacterial physiology and potential therapeutic targets. Patients may benefit from this research as it could lead to improved treatments for bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with bacterial infections, particularly those caused by E. coli.
Not a fit: Patients with viral infections or non-bacterial related conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating bacterial infections by enhancing our understanding of bacterial survival mechanisms.
How similar studies have performed: Other research has shown success in understanding bacterial responses to stress, making this approach promising but still exploring novel aspects.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Alexander, Sara — University of Pennsylvania
- Study coordinator: Alexander, Sara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.